The Use of Vascular Endothelial Growth Factor Inhibitors in Patients with Proliferative Diabetic Retinopathy
Diabetic retinopathy (DR) have been taking a leading position among retinal disorders, causing a persistent and significant decrease in visual functions. The base of the disease is a retinal vascular microangiopathy, which induces a tissue ischemia and excessive production of vascular endothelial gr...
Saved in:
| Main Authors: | V. Yu. Evgrafov, G. R. Kudasheva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2022-07-01
|
| Series: | Oftalʹmologiâ |
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/1867 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFECT OF SURGICAL TREATMENT OF PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY COMPLICATED BY HEMOPHTHALMIA
by: V. D. Zaharov, et al.
Published: (2017-10-01) -
Patient with severe proliferative diabetic retinopathy and comorbidity: analysis of solved and unsolved problems in diabetic retinal involvement diagnosis and treatment from the point of real-world clinical practice and clinical guidelines
by: T. A. Novikova-Bilak, et al.
Published: (2025-02-01) -
Results of a New Virtual Program for Patients Overdue for Diabetic Retinopathy Evaluation
by: Shannan G. Moore, et al.
Published: (2025-04-01) -
Reduced rates of diabetic retinopathy complications with use of continuous glucose monitoring
by: Amer F. Alsoudi, et al.
Published: (2025-07-01) -
Applying Lucentis for the treatment of retinopathy of prematurity
by: S. V. Lesovoy, et al.
Published: (2022-12-01)